The Morning Briefing: Vaccination trials, research

Summary:"The Morning Briefing" is SmartPlanet's daily roundup of must-reads from the web. This morning we're reading about vaccination trials and research.

"The Morning Briefing" is SmartPlanet's daily roundup of must-reads from the web. This morning we're reading about vaccination trials and research.

1.) First alcoholism vaccine to begin preclinical trials. Testing on a vaccine for alcoholism is about to begin in Chile.

2.) Call for boy cancer vaccine. A new charity is urging the U.K. government to deal with the 'ticking time bomb' that is throat cancer.

3.) BCG vaccine lab ready to start operations. The BCG Vaccine Laboratory, shut down nearly four years ago, is once again ready to serve its raison d'etre -- launch into the production mode for the BCG vaccine, which provides early life protection against tuberculosis.

4.) Volunteers wanted for bird flu vaccine. Researchers in Newcastle are doing their bit to help protect the world against a potentially deadly outbreak of the bird flu virus.

5.) No TB cattle vaccine until 2023 –- E.U. Commission. The European Commission has told Defra that a cattle vaccine for bovine TB (bTB) is unlikely to be commercially available until 2023.

Photo Credit: blakespot

Related:

This post was originally published on Smartplanet.com

Topics: Innovation

About

Charlie Osborne, a medical anthropologist who studied at the University of Kent, UK, is a journalist, freelance photographer and former teacher. She has spent years travelling and working across Europe and the Middle East as a teacher, and has been involved in the running of businesses ranging from media and events to B2B sales. Charli... Full Bio

zdnet_core.socialButton.googleLabel Contact Disclosure

Kick off your day with ZDNet's daily email newsletter. It's the freshest tech news and opinion, served hot. Get it.

Related Stories

The best of ZDNet, delivered

You have been successfully signed up. To sign up for more newsletters or to manage your account, visit the Newsletter Subscription Center.
Subscription failed.